Drug Discovery aims to develop pipeline of transformative medicines
Partner
1 Product candidates in development as part of our worldwide collaboration and license agreement with Genentech. The first shared and second shared cell therapy product candidates refer to the two lead clinical product candidates selected from our library of TCRs that target cancer antigens present in many cancer patients. Genentech will determine the timing of discussions with, and submissions to, the FDA.